We also assessed the effect of p53 deletion on transposable element expression in tumors by evaluating transposable element expression in NPp53, NP prostate tumors and control Nkx3.1-CreERT2 (N) prostate tissues [35] (Fig. S2H). The gene discussed is NKX3-1; the disease is prostate neoplasm.